Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue - Other
Ratios

Mereo BioPharma (MREO) Cost of Revenue (2023 - 2025)

Historic Cost of Revenue for Mereo BioPharma (MREO) over the last 2 years, with Q2 2025 value amounting to $100000.0.

  • Mereo BioPharma's Cost of Revenue changed N/A to $100000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $100000.0, marking a year-over-year increase of 13663.0%. This contributed to the annual value of $2.6 million for FY2023, which is 12460.73% up from last year.
  • Mereo BioPharma's Cost of Revenue amounted to $100000.0 in Q2 2025.
  • Over the past 5 years, Mereo BioPharma's Cost of Revenue peaked at $3.4 million during Q2 2023, and registered a low of -$273000.0 during Q4 2023.